                         SEQUENCE LISTING

<110>  Development Center for Biotechnology
       DCB-USA LLC
 
<120>  Light Chain Bridged Bispecific Antibody

<130>  17787/005WO1

<150>  US 61/580,491
<151>  2011-12-27

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  105
<212>  PRT
<213>  Homo sapiens

<400>  1

Val Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu 
1               5                   10                  15      


Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro 
            20                  25                  30          


Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly 
        35                  40                  45              


Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr 
    50                  55                  60                  


Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His 
65                  70                  75                  80  


Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val 
                85                  90                  95      


Thr Lys Ser Phe Asn Arg Gly Glu Cys 
            100                 105 


<210>  2
<211>  106
<212>  PRT
<213>  Homo sapiens

<400>  2

Gly Gln Pro Lys Ala Ala Pro Ser Val Thr Leu Phe Pro Pro Ser Ser 
1               5                   10                  15      


Glu Glu Leu Gln Ala Asn Lys Ala Thr Leu Val Cys Leu Ile Ser Asp 
            20                  25                  30          


Phe Tyr Pro Gly Ala Val Thr Val Ala Trp Lys Ala Asp Gly Ser Pro 
        35                  40                  45              


Val Lys Ala Gly Val Glu Thr Thr Thr Pro Ser Lys Gln Ser Asn Asn 
    50                  55                  60                  


Lys Tyr Ala Ala Ser Ser Tyr Leu Ser Leu Thr Pro Glu Gln Trp Lys 
65                  70                  75                  80  


Ser His Arg Ser Tyr Ser Cys Gln Val Thr His Glu Gly Ser Thr Val 
                85                  90                  95      


Glu Lys Thr Val Ala Pro Thr Glu Cys Ser 
            100                 105     


<210>  3
<211>  120
<212>  PRT
<213>  Homo sapiens

<400>  3

Val Thr His Val Phe Gly Ser Gly Thr Gln Leu Thr Val Leu Ser Gln 
1               5                   10                  15      


Pro Lys Ala Thr Pro Ser Val Thr Leu Phe Pro Pro Ser Ser Glu Glu 
            20                  25                  30          


Leu Gln Ala Asn Lys Ala Thr Leu Val Cys Leu Met Asn Asp Phe Tyr 
        35                  40                  45              


Pro Gly Ile Leu Thr Val Thr Trp Lys Ala Asp Gly Thr Pro Ile Thr 
    50                  55                  60                  


Gln Gly Val Glu Met Thr Thr Pro Ser Lys Gln Ser Asn Asn Lys Tyr 
65                  70                  75                  80  


Ala Ala Ser Ser Tyr Leu Ser Leu Thr Pro Glu Gln Trp Arg Ser Arg 
                85                  90                  95      


Arg Ser Tyr Ser Cys Gln Val Met His Glu Gly Ser Thr Val Glu Lys 
            100                 105                 110         


Thr Val Ala Pro Thr Glu Cys Ser 
        115                 120 


<210>  4
<211>  101
<212>  PRT
<213>  Homo sapiens

<400>  4

Thr Lys Gly Pro Ser Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr 
1               5                   10                  15      


Ser Gly Gly Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro 
            20                  25                  30          


Glu Pro Val Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val 
        35                  40                  45              


His Thr Phe Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser 
    50                  55                  60                  


Ser Val Val Thr Val Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile 
65                  70                  75                  80  


Cys Asn Val Asn His Lys Pro Ser Asn Thr Lys Val Asp Lys Lys Ala 
                85                  90                  95      


Glu Pro Lys Ser Cys 
            100     


